US2009311802A1PendingUtilityA1

Isolated Soluble IL-TIF/IL-22 Receptor or Binding Protein Which Binds to IL-TIF/IL-22 and Uses Thereof

59
Assignee: RENAULD JEAN-CHRISTOPHEPriority: Sep 22, 2000Filed: Jul 30, 2009Published: Dec 17, 2009
Est. expirySep 22, 2020(expired)· nominal 20-yr term from priority
Inventors:Jean-Christophe RenauldLaure Dumoutier
C07H 21/04C07K 14/7155
59
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The invention relates to soluble proteins which bind to the molecule known as IL-TIF/IL-22. The proteins can antagonize the effect of IL-TIF/IL-22 on target cells. The nucleic acid molecules encoding the proteins, and uses of the protein, are also described.

Claims

exact text as granted — not AI-modified
1 - 20 . (canceled) 
     
     
         21 . Isolated antibody which specifically binds to a protein comprising the amino acid sequence of SEQ ID NO:11. 
     
     
         22 . The antibody of  claim 21 , wherein said antibody is a monoclonal antibody. 
     
     
         23 . Hybridoma cell line which produces the monoclonal antibody of  claim 22 . 
     
     
         24 . A method for determining presence of a soluble protein which binds to IL-TIF/IL-22, comprising contacting said sample with the antibody of  claim 21 , and determining binding of said antibody to said soluble, binding protein as a determination of presence of said soluble, binding protein in said sample. 
     
     
         25 . The method of  claim 24 , wherein said antibody is labeled with a detectable label. 
     
     
         26 - 44 . (canceled)

Join the waitlist — get patent alerts

Track US2009311802A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.